A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101)
Takashina, Taichi, Asahina, Hajime, Oizumi, Satoshi, Yamada, Noriyuki, Harada, Masao, Takamura, Kei, Yokouchi, Hiroshi, Harada, Toshiyuki, Honjo, Osamu, Ogi, Takahiro, Morikawa, Naoto, Kinoshita, IchiМова:
english
Журнал:
International Journal of Clinical Oncology
DOI:
10.1007/s10147-018-1318-z
Date:
July, 2018
Файл:
PDF, 1.24 MB
english, 2018
File converter
Більше результатів пошуку
More benefits 
